Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Serif Biomedicines is pioneering Modified DNA as a new type of biotechnology.
Metaphore Biotechnologies is a firm that uses biomimicry and machine learning to unlock the revolutionary therapeutic.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Expedition Medicines develops an AI-powered platform that creates small-molecule drugs for previously inaccessible disease targets.
Extuitive is an AI-first business that aims to revolutionize the conception and validation of new consumer goods and creatives.
Terrana's innovative technology platform uses RNA-based plant health solutions to enable resilient agriculture for a world.
Etiome, a company redefining how we detect and preempt disease progression.
Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.
Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
Mirai Bio provides access to end-to-end development capabilities with innovation at every step.
Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.
Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.
CIBO scales regenerative advanced platform technology that connects growers to incentives and enterprises to growers.
Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.
Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Omega Therapeutics offers a proprietary epigenomic programming platform.
Montai Health platform enables rapid and repeatable advancement of therapies across multiple diseases.
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
Flagship Pioneering has invested in 70 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Flagship Pioneering's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Artificial Intelligence (AI). The firm invests across 23 different industry categories.
Among tracked funding rounds, Denali Therapeutics received $200.0M in a Post-IPO Debt round. Flagship Pioneering's total known invested capital is $4.6B.
Flagship Pioneering's average investment size is $65.8M across its portfolio of 70 companies.
Recent Flagship Pioneering portfolio additions include Serif Biomedicines, Metaphore Biotechnologies, Foghorn Therapeutics, Denali Therapeutics, Seres Therapeutics. These companies were founded in 2020 or later.